CXCL16 and intervertebral disk degenerative disorder: However, previous studies have not identified the specific molecular mechanism by which nucleus pulposus cell apoptosis occurs through the MAPK pathway, and the diagnostic biomarker we have selected this time, CXCL16, is likely to be involved in the MAPK pathway as a potential biomolecule that promotes IDD.